These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5805381)

  • 21. Clinical trial of intramuscular anti-snake venom administration as a first aid measure in the field in the management of Russell's viper bite patients.
    Win-Aung ; Tin-Tun ; Khin-Maung-Maung ; Aye-Kyaw ; Hla-Pe ; Tin-Nu-Swe ; Saw-Naing
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):494-7. PubMed ID: 9185259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Snakebite.
    Dutta TK; Mukta V
    J Indian Med Assoc; 2006 May; 104(5):250, 252-4. PubMed ID: 17058570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monospecific antivenin therapy in Russell's viper bite.
    Karnchanachetanee C; Hanvivatvong O; Mahasandana S
    J Med Assoc Thai; 1994 Jun; 77(6):293-7. PubMed ID: 7869015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast cells and local resistance to Russell's viper venom.
    Higginbotham RD
    J Immunol; 1965 Nov; 95(5):867-75. PubMed ID: 4954370
    [No Abstract]   [Full Text] [Related]  

  • 25. Detoxification of the venoms of the Russell's viper (Vipera russellii) and water moccasin (Agkistrodon piscivorus) by photooxidation. Rep No. 629.
    Kocholaty W; Ashley BD
    Rep US Army Med Res Lab; 1965 Apr; ():1-13. PubMed ID: 5295049
    [No Abstract]   [Full Text] [Related]  

  • 26. A new in-vitro agglutination technique for potency estimation of antisnake venom serum (ASVS).
    Chander R; Batra M; Singh D; Kumar Y; Rawat S; Kumar S
    Toxicon; 2006 Dec; 48(8):1011-7. PubMed ID: 16982078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralization of Vipera and Macrovipera venoms by two experimental polyvalent antisera: a study of paraspecificity.
    Archundia IG; de Roodt AR; Ramos-Cerrillo B; Chippaux JP; Olguín-Pérez L; Alagón A; Stock RP
    Toxicon; 2011 Jun; 57(7-8):1049-56. PubMed ID: 21530569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological studies on Naja nigricollis antivenin.
    Mohamed AH; Darwish MA; Hani-Ayobe M
    Toxicon; 1973 Jan; 11(1):35-8. PubMed ID: 4199121
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of passive haemagglutination (PHA) and haemagglutination inhibition (HAI) technique for potency estimation of Cobra Antisnake Venom Serum (ASVS).
    Pradhan S; Kumar S; Singh D; Sood RC; Sehgal R
    Biologicals; 2007 Jun; 35(3):155-60. PubMed ID: 17088076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interspecific variation in venom composition and toxicity of Brazilian snakes from Bothrops genus.
    Queiroz GP; Pessoa LA; Portaro FC; Furtado Mde F; Tambourgi DV
    Toxicon; 2008 Dec; 52(8):842-51. PubMed ID: 18983867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological studies on Egyptian cobra antivenin.
    Mohamed AH; Darwish MA; Hani-Ayobe M
    Toxicon; 1973 Jan; 11(1):31-4. PubMed ID: 4199120
    [No Abstract]   [Full Text] [Related]  

  • 32. Ventricular tachycardia, a rare manifestation of Russell's viper bite: case report.
    Thewjitcharoen Y; Poopitaya S
    J Med Assoc Thai; 2005 Dec; 88(12):1931-3. PubMed ID: 16518995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraspecific neutralization of the venom of African species of cobra by an equine antiserum against Naja melanoleuca: a comparative study.
    Casasola A; Ramos-Cerrillo B; de Roodt AR; Carbajal Saucedo A; Chippaux JP; Alagón A; Stock RP
    Toxicon; 2009 May; 53(6):602-8. PubMed ID: 19673073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survey of assay methods of antivenins; immunological factors influencing antivenin standardization.
    GRASSET E
    Bull World Health Organ; 1957; 16(1):79-122. PubMed ID: 13413648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of an antivenin against Vipera palestinae venom with high antineurotoxic potency.
    Moroz C; de Vries A; Goldblum N
    Toxicon; 1966 Nov; 4(3):205-8. PubMed ID: 6005011
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary observations on the venom of Wagler's pit viper (Trimeresurus wagleri).
    Minton SA
    Toxicon; 1968 Oct; 6(2):93-7. PubMed ID: 5721662
    [No Abstract]   [Full Text] [Related]  

  • 38. Cross neutralization of the coagulant activity of some snake venoms by antivenins.
    Rosenfeld G; Kelen EM
    Toxicon; 1966 Jun; 4(1):7-15. PubMed ID: 5963811
    [No Abstract]   [Full Text] [Related]  

  • 39. Antivenom treatment and renal dysfunction in Russell's viper snakebite in Taiwan: a case series.
    Hung DZ; Yu YJ; Hsu CL; Lin TJ
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):489-94. PubMed ID: 16325876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The production and control of anti--venous sera.
    Bolaños R; Cerdas L
    Dev Biol Stand; 1978; 41():109-16. PubMed ID: 89053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.